Tetraphase Pharmaceuticals Total Assets 2012-2019 | TTPH

Tetraphase Pharmaceuticals total assets from 2012 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Tetraphase Pharmaceuticals Annual Total Assets
(Millions of US $)
2018 $123
2017 $149
2016 $152
2015 $215
2014 $127
2013 $106
2012 $14
2011 $24
Tetraphase Pharmaceuticals Quarterly Total Assets
(Millions of US $)
Q2 2019 $90
Q1 2019 $109
Q4 2018 $123
Q3 2018 $111
Q2 2018 $122
Q1 2018 $129
Q4 2017 $149
Q3 2017 $172
Q2 2017 $128
Q1 2017 $135
Q4 2016 $152
Q3 2016 $171
Q2 2016 $188
Q1 2016 $202
Q4 2015 $215
Q3 2015 $229
Q2 2015 $250
Q1 2015 $270
Q4 2014 $127
Q3 2014 $61
Q2 2014 $79
Q1 2014 $93
Q4 2013 $106
Q3 2013 $73
Q2 2013 $81
Q1 2013 $81
Q4 2012 $14
Q3 2012 $0
Q2 2012 $0
Q1 2012 $0
Q4 2011 $24
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.008B $0.019B
Tetraphase Pharmaceuticals, Inc. is a life science company engaged in developing and commercializing tetracycline based drugs to treat drug-resistant infectious diseases, inflammation, and cancer. Its principal products include eravacycline, an intravenous and oral antibiotic for the treatment of multi-drug resistant Gram-negative infections. The Company's product under development includes eravacycline oral formulation, TP-834 and TP-271. Tetraphase Pharmaceuticals, Inc. is based in Watertown, Massachusetts.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $61.158B 9.66
Zoetis (ZTS) United States $55.822B 33.39
Astellas Pharma (ALPMY) Japan $32.413B 15.44
Eisai (ESALY) Japan $19.472B 37.55
Merck (MKGAF) Germany $15.591B 21.27
Grifols, S.A (GRFS) Spain $14.693B 18.75
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.259B 484.35
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $9.028B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.015B 16.23
Jazz Pharmaceuticals (JAZZ) Ireland $7.486B 9.56
Sage Therapeutics (SAGE) United States $7.312B 0.00
Catalent (CTLT) United States $7.236B 29.44
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.267B 18.93
Arrowhead Pharmaceuticals (ARWR) United States $4.293B 98.42
United Therapeutics (UTHR) United States $3.930B 0.00
Nektar Therapeutics (NKTR) United States $3.579B 0.00
Evotec AG (EVTCY) Germany $3.212B 52.56
FibroGen (FGEN) United States $3.091B 91.18
Taro Pharmaceutical Industries (TARO) Israel $2.934B 10.72
PTC Therapeutics (PTCT) United States $2.574B 0.00
Portola Pharmaceuticals (PTLA) United States $2.154B 0.00
Tilray (TLRY) Canada $2.106B 0.00
Xencor (XNCR) United States $1.972B 59.94
Zogenix (ZGNX) United States $1.963B 0.00
Corcept Therapeutics (CORT) United States $1.841B 22.38
Pacira Pharmaceuticals (PCRX) United States $1.788B 52.89
Ironwood Pharmaceuticals (IRWD) United States $1.780B 56.75
Heron Therapeutics (HRTX) United States $1.655B 0.00
USANA Health Sciences (USNA) United States $1.610B 17.18
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.212B 19.99
Radius Health (RDUS) United States $1.161B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.977B 0.00
Karyopharm Therapeutics (KPTI) United States $0.969B 0.00
ArQule (ARQL) United States $0.953B 0.00
Endo (ENDP) Ireland $0.938B 1.72
Spectrum Pharmaceuticals (SPPI) United States $0.915B 0.00
Aerie Pharmaceuticals (AERI) United States $0.875B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.808B 5.51
TherapeuticsMD (TXMD) United States $0.740B 0.00
Organogenesis Holdings (ORGO) United States $0.711B 0.00
Collegium Pharmaceutical (COLL) United States $0.642B 0.00
Flexion Therapeutics (FLXN) United States $0.609B 0.00
Translate Bio (TBIO) United States $0.565B 0.00
ChemoCentryx (CCXI) United States $0.559B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.506B 61.38
ImmunoGen (IMGN) United States $0.482B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.472B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.458B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.454B 0.00
Dermira (DERM) United States $0.441B 0.00
Siga Technologies (SIGA) United States $0.412B 9.41
Akebia Therapeutics (AKBA) United States $0.396B 0.00
Indivior (INVVY) United States $0.390B 1.41
DURECT (DRRX) United States $0.385B 0.00
OptiNose (OPTN) United States $0.383B 0.00
Recro Pharma (REPH) United States $0.383B 0.00
Ardelyx (ARDX) United States $0.381B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.380B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.374B 16.14
Innate Pharma SA (IPHYF) France $0.372B 0.00
Lannett Co Inc (LCI) United States $0.362B 4.22
Harpoon Therapeutics (HARP) United States $0.324B 0.00
Molecular Templates (MTEM) United States $0.323B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.282B 0.00
GlycoMimetics (GLYC) United States $0.258B 0.00
Rafael Holdings (RFL) United States $0.244B 0.00
Xeris Pharmaceuticals (XERS) United States $0.221B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.208B 0.00
KalVista Pharmaceuticals (KALV) United States $0.200B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.198B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.187B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.181B 31.23
MARKER THERAPEUTICS, INC (MRKR) United States $0.179B 0.00
Concert Pharmaceuticals (CNCE) United States $0.176B 0.00
Calithera Biosciences (CALA) United States $0.167B 0.00
Jounce Therapeutics (JNCE) United States $0.164B 2.19
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.153B 0.00
CV Sciences (CVSI) United States $0.152B 0.00
Aquestive Therapeutics (AQST) United States $0.144B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.142B 0.00
CannTrust Holdings (CTST) Canada $0.139B 0.00
MEI Pharma (MEIP) United States $0.138B 0.00
Redhill Biopharma (RDHL) Israel $0.134B 0.00
IMV INC (IMV) Canada $0.131B 0.00
Ocular Therapeutix (OCUL) United States $0.121B 0.00
Cardiome Pharma (CORV) Canada $0.119B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 25.77
Neos Therapeutics (NEOS) United States $0.079B 0.00
Majesco Entertainment (PTE) United States $0.078B 0.00
MediWound (MDWD) Israel $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Aclaris Therapeutics (ACRS) United States $0.075B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.073B 0.00
Generex Biotechnology (GNBT) United States $0.069B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
Champions Oncology (CSBR) United States $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.063B 0.00
Natural Alternatives (NAII) United States $0.063B 9.55
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.059B 0.00
Medicure (MCUJF) Canada $0.058B 0.00
Novan (NOVN) United States $0.057B 0.00
Genocea Biosciences (GNCA) United States $0.056B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
IntelGenx Technologies (IGXT) Canada $0.054B 0.00
AgeX Therapeutics (AGE) United States $0.054B 0.00
ElectroCore (ECOR) United States $0.054B 0.00
Infinity Pharmaceuticals (INFI) United States $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.048B 0.00
Jaguar Animal Health (JAGX) United States $0.046B 0.00
Nivalis Therapeutics (ALPN) United States $0.045B 0.00
Capnia (SLNO) United States $0.045B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
India Globalization Capital (IGC) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.034B 0.00
Mast Therapeutics (SVRA) United States $0.032B 0.00
Bio-Path Holdings (BPTH) United States $0.031B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Melinta Therapeutics (MLNT) United States $0.028B 0.00
PharmAthene (ALT) United States $0.027B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
IsoRay (ISR) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 17.17
Regulus Therapeutics (RGLS) United States $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Vical (BBI) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00